Inhibition of fluoropyrimidine catabolism by benzyloxybenzyluracil: Possible relevance to regional chemotherapy
- 15 June 1991
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 41 (12), 1887-1893
- https://doi.org/10.1016/0006-2952(91)90128-r
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Structure-activity relationship of ligands of dihydrouracil dehydrogenase from mouse liverBiochemical Pharmacology, 1989
- Effects of the Plasma Concentration of 5-Fluorouracil and the Duration of Continuous Venous Infusion of 5-Fluorouracil with an Inhibitor of 5-Fluorouracil Degradation on Yoshida Sarcomas in RatsJapanese Journal of Cancer Research, 1989
- Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil against adenocarcinoma 755 in mice: Increased therapeutic index and correlation with increased plasma 5-fluorouracil levelsBiochemical Pharmacology, 1988
- Intrahepatic or Systemic Infusion of Fluorodeoxyuridine in Patients with Liver Metastases from Colorectal CarcinomaAnnals of Internal Medicine, 1987
- The isolated perfused rat liver: Conceptual and practical considerationsHepatology, 1986
- Interaction of Mixed‐Function Oxidation with Biosynthetic ProcessesEuropean Journal of Biochemistry, 1973
- Studies on Fluorinated PyrimidinesPublished by Elsevier BV ,1960
- Studies on fluorinated pyrimidines: VII—the degradative pathwayBiochemical Pharmacology, 1959
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957
- PYRIMIDINE METABOLISMPublished by Elsevier BV ,1956